These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
932 related articles for article (PubMed ID: 32985513)
1. Structural and functional modelling of SARS-CoV-2 entry in animal models. Brooke GN; Prischi F Sci Rep; 2020 Sep; 10(1):15917. PubMed ID: 32985513 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors. Rangel HR; Ortega JT; Maksoud S; Pujol FH; Serrano ML Virus Res; 2020 Nov; 289():198154. PubMed ID: 32918944 [TBL] [Abstract][Full Text] [Related]
3. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2. Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139 [TBL] [Abstract][Full Text] [Related]
4. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart. Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018 [TBL] [Abstract][Full Text] [Related]
5. Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity. Sakaguchi W; Kubota N; Shimizu T; Saruta J; Fuchida S; Kawata A; Yamamoto Y; Sugimoto M; Yakeishi M; Tsukinoki K Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825469 [TBL] [Abstract][Full Text] [Related]
6. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein. Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194 [TBL] [Abstract][Full Text] [Related]
7. Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals. Hayashi T; Abiko K; Mandai M; Yaegashi N; Konishi I Vet Q; 2020 Dec; 40(1):243-249. PubMed ID: 32921279 [TBL] [Abstract][Full Text] [Related]
8. ACE2 and TMPRSS2 variation in savanna monkeys (Chlorocebus spp.): Potential risk for zoonotic/anthroponotic transmission of SARS-CoV-2 and a potential model for functional studies. Schmitt CA; Bergey CM; Jasinska AJ; Ramensky V; Burt F; Svardal H; Jorgensen MJ; Freimer NB; Grobler JP; Turner TR PLoS One; 2020; 15(6):e0235106. PubMed ID: 32574196 [TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. Zhang S; Liu Y; Wang X; Yang L; Li H; Wang Y; Liu M; Zhao X; Xie Y; Yang Y; Zhang S; Fan Z; Dong J; Yuan Z; Ding Z; Zhang Y; Hu L J Hematol Oncol; 2020 Sep; 13(1):120. PubMed ID: 32887634 [TBL] [Abstract][Full Text] [Related]
11. ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients. Ravaioli S; Tebaldi M; Fonzi E; Angeli D; Mazza M; Nicolini F; Lucchesi A; Fanini F; Pirini F; Tumedei MM; Cerchione C; Viale P; Sambri V; Martinelli G; Bravaccini S Cell Transplant; 2020; 29():963689720968749. PubMed ID: 33108902 [TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Hoffmann M; Kleine-Weber H; Schroeder S; Krüger N; Herrler T; Erichsen S; Schiergens TS; Herrler G; Wu NH; Nitsche A; Müller MA; Drosten C; Pöhlmann S Cell; 2020 Apr; 181(2):271-280.e8. PubMed ID: 32142651 [TBL] [Abstract][Full Text] [Related]
14. Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2. Basu A; Sarkar A; Maulik U Sci Rep; 2020 Oct; 10(1):17699. PubMed ID: 33077836 [TBL] [Abstract][Full Text] [Related]
15. Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19. Choudhary S; Silakari O Virus Res; 2020 Nov; 289():198146. PubMed ID: 32866534 [TBL] [Abstract][Full Text] [Related]
16. Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method. Lim H; Baek A; Kim J; Kim MS; Liu J; Nam KY; Yoon J; No KT Sci Rep; 2020 Oct; 10(1):16862. PubMed ID: 33033344 [TBL] [Abstract][Full Text] [Related]
17. Potential infectious risk from the pets carrying SARS-CoV-2. Wang H; Wang F; Wang H; Zhao Q Travel Med Infect Dis; 2020; 35():101737. PubMed ID: 32380152 [No Abstract] [Full Text] [Related]
18. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts. Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529 [TBL] [Abstract][Full Text] [Related]
19. Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates. Alazmi M; Motwalli O J Mol Model; 2020 Nov; 26(12):338. PubMed ID: 33175236 [TBL] [Abstract][Full Text] [Related]
20. Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2. Verkhivker G Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]